These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 11710717

  • 1. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.
    Silverman SL, Minshall ME, Shen W, Harper KD, Xie S, Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study.
    Arthritis Rheum; 2001 Nov; 44(11):2611-9. PubMed ID: 11710717
    [Abstract] [Full Text] [Related]

  • 2. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group.
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [Abstract] [Full Text] [Related]

  • 3. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
    Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL.
    J Rheumatol; 2003 Jul; 30(7):1579-83. PubMed ID: 12858462
    [Abstract] [Full Text] [Related]

  • 4. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.
    Oleksik AM, Ewing S, Shen W, van Schoor NM, Lips P.
    Osteoporos Int; 2005 Aug; 16(8):861-70. PubMed ID: 15558238
    [Abstract] [Full Text] [Related]

  • 5. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation.
    Siris E, Adachi JD, Lu Y, Fuerst T, Crans GG, Wong M, Harper KD, Genant HK.
    Osteoporos Int; 2002 Nov; 13(11):907-13. PubMed ID: 12415439
    [Abstract] [Full Text] [Related]

  • 6. [The impact of vertebral fractures on quality of life in postmenopausal women with osteoporosis. Validity of the Italian version of mini-Osteoporosis Quality of Life Questionnaire.].
    Salaffi F, Stancati A, Carotti M, Lorenzetti R, Grassi W.
    Reumatismo; 2005 Nov; 57(2):83-96. PubMed ID: 15983631
    [Abstract] [Full Text] [Related]

  • 7. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR.
    JAMA; 1999 Aug 18; 282(7):637-45. PubMed ID: 10517716
    [Abstract] [Full Text] [Related]

  • 8. Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial.
    Silverman S, Viswanathan HN, Yang YC, Wang A, Boonen S, Ragi-Eis S, Fardellone P, Gilchrist N, Lips P, Nevitt M, Palacios Gil-Antuñano S, Pavelka K, Revicki D, Simon J, Macarios D, Siris ES.
    Osteoporos Int; 2012 Apr 18; 23(4):1361-9. PubMed ID: 21769664
    [Abstract] [Full Text] [Related]

  • 9. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
    Crans GG, Silverman SL, Genant HK, Glass EV, Krege JH.
    Arthritis Rheum; 2004 Dec 18; 50(12):4028-34. PubMed ID: 15593198
    [Abstract] [Full Text] [Related]

  • 10. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH.
    J Bone Joint Surg Am; 2009 Jun 18; 91(6):1329-38. PubMed ID: 19487509
    [Abstract] [Full Text] [Related]

  • 11. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.
    Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J.
    J Bone Miner Res; 2000 Jul 18; 15(7):1384-92. PubMed ID: 10893688
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL, Shen W, Minshall ME, Xie S, Moses KH.
    J Rheumatol; 2007 Jan 18; 34(1):140-4. PubMed ID: 17216681
    [Abstract] [Full Text] [Related]

  • 13. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
    Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD.
    Bone; 2003 Oct 18; 33(4):522-32. PubMed ID: 14555255
    [Abstract] [Full Text] [Related]

  • 14. Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent.
    Kim SH, Choi HS, Rhee Y, Kim KJ, Lim SK.
    Osteoporos Int; 2011 Mar 18; 22(3):781-7. PubMed ID: 20533028
    [Abstract] [Full Text] [Related]

  • 15. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis.
    Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD.
    Arch Intern Med; 2002 May 27; 162(10):1140-3. PubMed ID: 12020184
    [Abstract] [Full Text] [Related]

  • 16. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F, Malavolta N, Cimmino MA, Di Matteo L, Scendoni P, Carotti M, Stancati A, Mulé R, Frigato M, Gutierrez M, Grassi W, Italian Multicentre Osteoporotic Fracture (IMOF) Study Group.
    Clin Exp Rheumatol; 2007 May 27; 25(3):390-403. PubMed ID: 17631735
    [Abstract] [Full Text] [Related]

  • 17. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis.
    Silverman SL, Piziak VK, Chen P, Misurski DA, Wagman RB.
    J Rheumatol; 2005 Dec 27; 32(12):2405-9. PubMed ID: 16331772
    [Abstract] [Full Text] [Related]

  • 18. The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women.
    Fechtenbaum J, Cropet C, Kolta S, Horlait S, Orcel P, Roux C.
    Osteoporos Int; 2005 Dec 27; 16(12):2175-9. PubMed ID: 16220230
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life and radiographic vertebral fracture.
    Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis JA, Kiss C, Masaryk P, Naves M, Poor G, Raspe H, Reid DM, Reeve J, Stepan J, Todd C, Woolf AD, O'Neill TW.
    Osteoporos Int; 2004 Feb 27; 15(2):113-9. PubMed ID: 14618303
    [Abstract] [Full Text] [Related]

  • 20. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.
    Kanis JA, Johnell O, Black DM, Downs RW, Sarkar S, Fuerst T, Secrest RJ, Pavo I.
    Bone; 2003 Sep 27; 33(3):293-300. PubMed ID: 13678769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.